Yvonne Commodore-Mensah, Oluwabunmi Ogungbe, Eric Broni, Camillus Ezeike, Ruth-Alma Turkson-Ocran, Jennifer Wenzel, Lisa A Cooper
African Immigrants' perceptions and attitudes toward cardiovascular health
Journal of advanced nursing
atrial fibrillation af significantly heightens stroke risk mitigated anticoagulation therapy although warfarin traditionally employed purpose use directacting oral anticoagulants doacs rise retrospective study spanned june 2016 january 2018 focused adult patients diagnosed af treatments either via warfarin doacs apixaban rivaroxaban dabigatran evaluated data analysis done using statistical product service solutions spss version 21 ibm spss statistics windows armonk ny study aims evaluate safety effectiveness doacs versus warfarin preventing thromboembolic complications among saudi patients af total 396 patients af averaging 66 14 years age part study among slightly female patients 205 518 majority patients 223 563 treated doac rest 173 437 received warfarin furthermore 93 patients 235 taking antiplatelet drugs statistically rate ischemic stroke significantly higher among patients treated doacs warfarin p0005 bleeding rates similar groups specifically doacs apixaban rivaroxaban showed significant association occurrence stroke compared warfarin p0012 p007 respectively overall doacs warfarin presented similar results regarding hemorrhagic complications treating af patients however doacs apixaban rivaroxaban displayed higher risks ischemic stroke compared warfarin